Matthew D. Lauver

Matthew D. Lauver

Auto-generated profile, based on publicly available information

Matthew D. Lauver

Department of Cell and Biological Systems, Pennsylvania State University College of Medicine, Hershey, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
TMTaryn E. Mockus
Taryn E. Mockus
SHShwetank
Shwetank
MLMatthew D. Lauver
Matthew D. Lauver
HRHeather M. Ren
Heather M. Ren
CNColleen Netherby-Winslow
Colleen Netherby-Winslow
ALAron Lukacher
Aron Lukacher
Tissue-resident memory CD8 T (TRM) cells defend against microbial reinfections at mucosal barriers; determinants driving durable TRM cell responses in non-mucosal tissues, which often harbor opportunistic persistent pathogens, are unknown. JC polyomavirus (JCPyV) is a ubiquitous constituent of the human virome. With altered immunological status, JCPyV can cause the oft-fatal brain demyelinating disease progressive multifocal leukoencephalopathy (PML). JCPyV is a human-only pathogen. Using the mouse polyomavirus (MuPyV) encephalitis model, we demonstrate that CD4 T cells regulate development of functional antiviral brain-resident CD8 T cells (bTRM) and renders their maintenance refractory to systemic CD8 T cell depletion. Acquired CD4 T cell deficiency, modeled by delaying systemic CD4 T cell depletion until MuPyV-specific CD8 T cells have infiltrated the brain, impacted the stability of CD8 bTRM, impaired their effector response to reinfection, and rendered their maintenance dependent on circulating CD8 T cells. This dependence of CD8 bTRM differentiation on CD4 T cells was found to extend to encephalitis caused by vesicular stomatitis virus. Together, these findings reveal an intimate association between CD4 T cells and homeostasis of functional bTRM to CNS viral infection. Tissue resident memory cells (TRM) persist in nonlymphoid organs serving as frontline defense against microbial reinfection. The requirements for generating pathogen-specific TRM to acutely resolved infections is well documented; however, little is known about the development of TRM to persistent infections. In this study, we investigated the importance of CD4 T cell availability to CD8 TRM development during persistent viral encephalitis. Using mouse polyomavirus (MuPyV) brain infection and systemic CD4 T cell insufficiency, we found that loss of CD4 T cells abrogated brain TRM (bTRM) development, disrupted the metabolic homeostasis of CD8 T cells, and reduced CD8 T cell responses upon viral reinfection. Additionally, CD8 T cells in CD4 T cell-deficient mice required resupply from circulating CD8 T cells, directly contrasting the independence from circulation in canonical TRM. Upon delayed CD4 T cell depletion and brain infection with an acutely resolving viral infection, CD8 T cells also had aberrant bTRM development and required resupply from the vasculature. Our findings demonstrate that CD4 T cells are essential for establishing long-lasting, virus-specific CD8 bTRM for antiviral CNS immunosurveillance. Our data also raise important clinical implications for developing therapies to augment CD4 T cell help to bolster protective CD8 bTRM responses.

27 December 2017 in mSphere
Verified
Journal Article
Open access
SMSaumya Maru
Saumya Maru
GJGe Jin
Ge Jin
DDDhimant Desai
Dhimant Desai
SAShantu Amin
Shantu Amin
SHShwetank
Shwetank
ALAron Lukacher
Aron Lukacher
PyVs can cause significant morbidity and mortality in immunocompromised individuals. No clinically efficacious anti-PyV therapeutic agents are available. A recently identified inhibitor of retrograde transport, Retro-2 cycl , blocks movement of PyV virion-containing vesicles from early endosomes to the endoplasmic reticulum, an early step in the PyV life cycle. Retro-2 cycl and its derivatives have been shown to inhibit infection by human PyVs in tissue culture. Here, we demonstrate that a derivative of Retro-2 cycl , Retro-2.1, reduces infection by MuPyV in the kidneys of acutely infected mice. Mimicking the common clinical scenario of PyV resurgence, we further show that MuPyV levels increase in the kidneys of immunocompromised, persistently infected mice and that this increase is inhibited by Retro-2.1. These data provide the first evidence for control of a natural PyV infection in vivo by administration of an inhibitor of retrograde transport.

17 September 2020 in eLife
Verified
Journal Article
Open access
MLMatthew D Lauver
Matthew D Lauver
DGDaniel James Goetschius
Daniel James Goetschius
CNColleen S Netherby-Winslow
Colleen S Netherby-Winslow
KAKatelyn N Ayers
Katelyn N Ayers
GJGe Jin
Ge Jin
ALAron Lukacher
Aron Lukacher
JCPyV polyomavirus, a member of the human virome, causes progressive multifocal leukoencephalopathy (PML), an oft-fatal demyelinating brain disease in individuals receiving immunomodulatory therapies. Mutations in the major viral capsid protein, VP1, are common in JCPyV from PML patients (JCPyV-PML) but whether they confer neurovirulence or escape from virus-neutralizing antibody (nAb) in vivo is unknown. A mouse polyomavirus (MuPyV) with a sequence-equivalent JCPyV-PML VP1 mutation replicated poorly in the kidney, a major reservoir for JCPyV persistence, but retained the CNS infectivity, cell tropism, and neuropathology of the parental virus. This mutation rendered MuPyV resistant to a monoclonal Ab (mAb), whose specificity overlapped the endogenous anti-VP1 response. Using cryo-EM and a custom sub-particle refinement approach, we resolved an MuPyV:Fab complex map to 3.2 Å resolution. The structure revealed the mechanism of mAb evasion. Our findings demonstrate convergence between nAb evasion and CNS neurovirulence in vivo by a frequent JCPyV-PML VP1 mutation.

7 November 2022 in eLife
Verified
Journal Article
Open access
MLMatthew D Lauver
Matthew D Lauver
GJGe Jin
Ge Jin
KAKatelyn N Ayers
Katelyn N Ayers
SCSarah N Carey
Sarah N Carey
CSCharles S Specht
Charles S Specht
ALAron Lukacher
Aron Lukacher
JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease in immunocompromised patients. Inherited and acquired T cell deficiencies are associated with PML. The incidence of PML is increasing with the introduction of new immunomodulatory agents, several of which target T cells or B cells. PML patients often carry mutations in the JCPyV VP1 capsid protein, which confer resistance to neutralizing VP1 antibodies (Ab). Polyomaviruses (PyV) are tightly species-specific; the absence of tractable animal models has handicapped understanding PyV pathogenesis. Using mouse polyomavirus (MuPyV), we found that T cell deficiency during persistent infection, in the setting of monospecific VP1 Ab, was required for outgrowth of VP1 Ab-escape viral variants. CD4 T cells were primarily responsible for limiting polyomavirus infection in the kidney, a major reservoir of persistent infection by both JCPyV and MuPyV, and checking emergence of these mutant viruses. T cells also provided a second line of defense by controlling the outgrowth of VP1 mutant viruses that evaded Ab neutralization. A virus with two capsid mutations, one conferring Ab-escape yet impaired infectivity and a second compensatory mutation, yielded a highly neurovirulent variant. These findings link T cell deficiency and evolution of Ab-escape polyomavirus VP1 variants with neuropathogenicity.

5 January 2017 in Virology
Verified
Journal Article
Closed access
QQQingsong Qin
Qingsong Qin
MLMatthew Lauver
Matthew Lauver
SMSaumya Maru
Saumya Maru
ELEugene Lin
Eugene Lin
ALAron Lukacher
Aron Lukacher

25 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KAKatelyn N Ayers
Katelyn N Ayers
MLMatthew D Lauver
Matthew D Lauver
KAKalynn M Alexander
Kalynn M Alexander
GJGe Jin
Ge Jin
KPKitt Paraiso
Kitt Paraiso
ALAron Lukacher
Aron Lukacher
How changes in the quality of anti-viral antibody (Ab) responses due to pre-existing or acquired CD4 T cell insufficiency affect virus evolution during persistent infection are unknown. Using mouse polyomavirus (MuPyV), we found that CD4 T cell depletion before infection results in short-lived plasma cells secreting low-avidity antiviral IgG with limited BCR diversity and weak virus-neutralizing ability. CD4 T cell deficiency during persistent infection incurs a shift from a T-dependent (TD) to T-independent (TI) Ab response, resembling the pre-existing TI Ab response. CD4 T cell loss before infection or during persistent infection is conducive for emergence of Ab-escape variants. Cryo-EM reconstruction of complexes of MuPyV virions with polyclonal IgG directly from infected mice with pre-existing or acquired CD4 T cell deficiency enabled visualization of shortfalls in TI IgG binding. By debilitating the antiviral IgG response, CD4 T cell deficiency sets the stage for outgrowth of variant viruses resistant to neutralization. ONE SENTENCE SUMMARY Pre-existing and acquired CD4 T cell deficiency facilitates outgrowth of Ab-escape viral variants during persistent infection.